Trial Profile
Open-Label, Pilot Phase I/II Study of the Efficacy and Safety of APD209 in Patients With Cachexia and Advanced Malignancy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 May 2014
Price :
$35
*
At a glance
- Drugs Formoterol/megestrol (Primary)
- Indications Cachexia
- Focus Therapeutic Use
- Sponsors Acacia Pharma
- 02 May 2014 New trial record